Skip to content

US · BYAH · HOUSEHOLD & PERSONAL PRODUCTS

Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) intrinsic value and stock valuation

$0.85as of 2026-11-21 · Mkt cap 2.35M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Park Ha Biological Technology Co., Ltd. Ordinary Shares DCF and intrinsic value

InvestorsCraft values BYAH with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BYAH’s statements →

Park Ha Biological Technology Co., Ltd. Ordinary Shares Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Consumer Defensive · Household & Personal Products Wuxi, JS 214000 parkha.cn

How the business is doing

Fiscal 2021–2025, USD

Revenue
$2.52M
20212025
Net income
-$-24.36M
20212025
Free cash flow
-$0.00
20212025
Total equity
$3.99M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$2.52M$2.38M$2.46M$1.92M$930K
Operating income-$-24.15M$790K$1.18M$200K-$-500K
Net income-$-24.36M$480K$850K$190K-$-480K
EPSd-$-348M$6.86M$12.1M$2.71M-$-6.86M
Operating cash flow$90K$960K$130K$1.44M-$-500K
Capital expenditure-$-90K-$-90K-$-20K-$-10K-$-10K
Free cash flow-$0.00$870K$100K$1.43M-$-510K
Total assets$5.95M$3.08M$2.26M$2.52M$590K
Total debt$180K$70K$30K$30K$40K
Net debt-$-3.61M-$-480K-$-1M-$-550K-$-40K
Total equity$3.99M$1.51M$1.01M$150K-$-580K
Cash and short-term investments$3.79M$550K$1.03M$570K$70K
Income statement
20252024202320222021
Revenue$2.52M$2.38M$2.46M$1.92M$930K
Cost of revenue$140K$200K$310K$510K$310K
Gross profit$2.38M$2.19M$2.15M$1.41M$620K
Research and development expenses$240K$40K$30K$60K$50K
Selling, general and administrative expenses$26.1M$1.18M$780K$1.15M$1.12M
Other expenses$180K$180K$150K$10K-$-50K
Operating expenses$26.5M$1.39M$970K$1.21M$1.12M
Cost and expenses$26.7M$1.59M$1.28M$1.72M$1.43M
Interest income$10K$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$110K$20K$20K$30K$40K
Ebitda-$-23.97M$820K$1.2M$220K-$-440K
Operating income-$-24.15M$790K$1.18M$200K-$-500K
Total other income/expenses, net$60K-$0.00$0.00-$-10K$20K
Income before tax-$-24.08M$790K$1.18M$190K-$-480K
Income tax expense$280K$310K$330K-$0.00$0.00
Net income-$-24.36M$480K$850K$190K-$-480K
Weighted average shares outstanding$70K$70K$70K$70K$70K
Weighted average diluted shares outstanding$70K$70K$70K$70K$70K
Balance sheet
20252024202320222021
Cash and short-term investments$3.79M$550K$1.03M$570K$70K
Net receivables$1.3M$1.11M$710K$1.53M$80K
Inventory$80K$70K$100K$90K$320K
Total current assets$5.5M$2.84M$2.18M$2.26M$470K
Property, plant and equipment, net$340K$170K$70K$60K$110K
Goodwill and intangible assets$10K$10K$10K$10K$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$450K$240K$90K$250K$120K
Total assets$5.95M$3.08M$2.26M$2.52M$590K
Accounts payable$10K$20K$200K$130K$90K
Short-term debt$100K$20K$20K$30K$20K
Deferred revenue$190K$330K$250K$1.21M$160K
Total current liabilities$1.88M$1.52M$1.24M$2.37M$1.16M
Long-term debt$80K$50K$10K$0.00$20K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$80K$50K$10K$0.00$20K
Capital lease obligations$80K$70K$30K$30K$40K
Total liabilities$1.96M$1.58M$1.25M$2.37M$1.17M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-24.18M$270K-$-110K-$-930K-$-1.12M
Accumulated other comprehensive income (loss)$150K$70K-$-40K-$-50K-$-50K
Total equity$3.99M$1.51M$1.01M$150K-$-580K
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$180K$70K$30K$30K$40K
Net debt-$-3.61M-$-480K-$-1M-$-550K-$-40K
Cash flow statement
20252024202320222021
Net income-$-24.36M$480K$850K$190K-$-480K
Depreciation and amortization$110K$20K$20K$30K$40K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-90K$250K-$-910K$1.17M-$-50K
Accounts receivable-$-250K-$-140K-$-600K-$-140K-$-50K
Inventory-$-10K$10K-$0.00$190K-$-20K
Accounts payable-$-10K-$-180K$70K$60K$40K
Net cash provided by operating activities$90K$960K$130K$1.44M-$-500K
Investments in property, plant and equipment-$-90K-$-90K-$-20K-$-10K-$-10K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-570K-$-510K$1.02M-$-1.55M-$-10K
Common stock issued$3.73M$0.00$40K$530K$260K
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$3.74M-$-960K-$-680K$670K$500K
Net change in cash$3.24M-$-490K$460K$500K-$-10K
Cash at end of period$3.79M$550K$1.03M$570K$70K
Operating cash flow$90K$960K$130K$1.44M-$-500K
Capital expenditure-$-90K-$-90K-$-20K-$-10K-$-10K
Free cash flow-$0.00$870K$100K$1.43M-$-510K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Park Ha Biological Technology Co., Ltd. Ordinary Shares

        This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.

        CEO
        Xiaoqiu Zhang
        Employees
        41
        Beta
        0.18

        Explore

        Frequently asked questions

        What is the intrinsic value of Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)?

        InvestorsCraft does not currently publish an intrinsic value for BYAH. How the IC value is calculated.

        Is BYAH undervalued?

        InvestorsCraft does not publish an undervaluation signal for BYAH at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.